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Case Reports(1/12; 8.3%). Overall, ECMO weaning with decannulation
was achieved in 14 patients (46.6%).
Three patients died in the hospital 9, 35, and 40 days after
ECMO discontinuation and decannulation for septic shock
(2 of them were in the bridge group). The overall survival at
discharge was 36.6% (11/30 patients).
DISCUSSION
ECMO support is currently required to allow a patient’s
recovery after cardiac surgery, after cardiopulmonary arrest
refractory to resuscitation maneuvers, or after severe respi-
ratory damage.3-5 A specialized 24-hour in-house ECMO
team is usually necessary to monitor patient’s parameters
continuously to guarantee the best possible outcome1-4;
this requires a great economic investment and is generally
possible in large-volume pediatric heart centers with great
financial resources.
The weaning from ECMO support is always a delicate
phase in the management of heart and lung recovery, and
constant observation of the patient’s hemodynamic status
is mandatory, together with continuous flushing of the cir-
cuit and cannulas when ECMO is temporarily stopped to
prevent the risk of clot formation and systemic embo-
lism.2-3 In our unit, because of the lack of a dedicated
24-hour in-house ECMO team, a strict and tireless cooper-
ation among cardiac surgeons, nursing personnel, and per-
fusionists is essential for buffering our limited resources.
For these reasons, we have developed the simplified wean-
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ECMO circuit recirculating at the bed space and ready to
be restarted in a few seconds if needed.
The simplified weaning bridge can be used without addi-
tional human and economic resources. With the bridge,
ECMO can be restarted fast and safely (so long as it was
not discontinued for any hemorrhagic or thromboembolic
complications) just by removing 2 tubing clamps, without
emergency resuscitation maneuvers or a new cannulation,
thus obviating the need for surgeons or other specialized
technicians. The introduction of the simplified weaning
bridge into our therapeutic armamentarium allows us to
be more liberal in the process of weaning patients from
ECMO because of the easy possibility of restarting the
support.
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Fausto Chilovi, MD,b and Gino Gerosa, MD,a Padova and Bolzano, ItalyGastrointestinal (GI) bleeding is a common and serious
problem in patients with continuous-flow left ventricular
assist devices (LVADs).1,2 Thus in a clinical context it is
crucial to adopt the most effective diagnostic strategy and
where possible use noninvasive procedures to limit the
infective and hemorrhagic burden.
We report the case of a patient with significant GI bleed-
ing after implantation of a Jarvik 2000 LVAD (Jarvik Heart,
Inc, New York, NY). The sources of the bleeding were
successfully identified by wireless PillCam SB capsule
videoendoscopy (VCE) (Given Imaging, Yoqneam, Israel)ery c April 2012
FIGURE 1. A, PillCam SB capsule videoendoscope showing several jejunal lesions with active bleeding and small bowel angiodysplasias. B, Several
angiodyplasias were successfully treated with argon plasma coagulation during double balloon enteroscopy. C, Dieulafoy lesion was successfully treated
with argon plasma coagulation during double balloon enteroscopy.
Case Reportsand were successfully treated by argon plasma coagulation
during a double balloon enteroscopy (DBE).
CLINICAL SUMMARY
A 69-year-old man with a history of large anterior wall
myocardial infarction, coronary artery bypass graft, im-
plantable cardioverter-defibrillator (ICD) implantation,
and renal failure was admitted to our institution for refrac-
tory heart failure despite maximal medical treatment. He
was assessed as suitable for destination therapy withThe Journal of Thoracic and Caimplantation of a Jarvik 2000 LVAD, which was per-
formed through a left thoratocomy without cardiopulmo-
nary bypass. The early postoperative course was largely
uneventful.
Intravenous heparin (activated partial thromboplastin
time, 50-55 seconds) and then oral warfarin were adminis-
tered with the aim of achieving an international normalized
ratio of 2.0 to 2.5.
A dose of 100 mg of aspirin was given daily from the
second postoperative day.rdiovascular Surgery c Volume 143, Number 4 e29
FIGURE 2. Diagnostic and therapeutic algorithm for occult gastrointestinal (GI) bleeding in a patient with a left ventricular assist device (LVAD). EGDS,
Esophagogastroduodenoscopy; VCE, PillCam SB capsule videoendoscopy; DBE, double balloon enteroscopy.
Case ReportsThe antithrombotic treatment was monitored and
calibrated after thromboelastometry (ROTEM; Tem Inter-
national GmbH, Munich, Germany) to avoid both a hyper-
coagulant or hypocoagulant state and aggregometry
(Multiplate analyzer; Dynabyte Informationssysteme
GmbH, Munich, Germany) serial evaluations to adjust the
antiplatelet therapy.
One month after implantation, the patient began having
dark, foul-smelling stools. Esophagogastroduodenoscopy
and colonscopy revealed no pathologic findings. Aspirin
and warfarin were discontinued and low molecular weight
heparin was introduced. The patient underwent several
blood transfusions and subcutaneous octreotide treatment
did not resolve the bleeding. During the following days,
melena persisted and the hemoglobin concentration de-
creased. A push enteroscopy revealed 2 angiodysplasias
with active bleeding that were treated with argon plasma
coagulation.
Nevertheless, melena and anemia persisted and bleed-
ing from the small intestine appeared to be most likely.
After conventional preparation, wireless VCE was per-
formed with the PillCam SB2 capsule endoscope. There
were no problems with passage of the capsule or signal
transmission, and no malfunction of the Jarvik 2000
and ICD occurred. Analysis of the data captured revealed
several jejunal lesions with active bleeding and small
bowel angiodysplasias (Figure 1, A). A deep DBE was
performed with the assistance of a cardiothoracic surgeon
and cardiac anesthesiologist. The patient was kept supinee30 The Journal of Thoracic and Cardiovascular Surgand care was taken to avoid upper abdominal pressure on
or near the LVAD. With an initial oral approach under
general anesthesia, 6 angiodyplasias distal to the liga-
ment of Treiz and 1 distal jejunal Dieulafoy lesion
were successfully treated with argon plasma coagulation
(Figure 1, B and C). The rectal approach under sedation
revealed no lesions. Both procedures were uneventful.
The patient had no further GI bleeding and was dis-
charged home 1 week after the procedure. Once the
bleeding was stopped, we restarted oral warfarin alone,
achieving an international normalized ratio of 2.0 to
2.5 without further complications.
DISCUSSION
GI bleeding is a widely known complication in patients
with LVADs, and its occurrence is promoted by multiple
comorbidities present and the need for antithrombotic ther-
apy. Additionally, continuous-flow LVADs may cause an
acquired von Willebrand disease contributing to bleeding
in the presence of GI angiodisplasias.3-5 These vascular
malformations may be located anywhere in the GI tract,
and it may be necessary to visualize the entire small
intestine if esophagogastroduodenoscopy and colonoscopy
are nondiagnostic. In this situation it is crucial to proceed
with the most accurate diagnostic strategy, paying
attention to use noninvasive procedures to limit the
infective and hemorragic risks. To this end, wireless VCE
and deep DBE have become important diagnostic and
therapeutic tools. There is some concern that wirelessery c April 2012
Case Reportssignal transmission from the capsule might be disturbed by
the electromagnetic field of the LVAD or ICD.3-6 On the
other hand, the LVAD and ICD could be disturbed by the
capsule. In our case, no interactions were observed among
the Jarvik 2000, the ICD (CONTAK RENEWAL TR
cardiac resynchronization therapy pacemaker; Boston
Scientific, Boston, Mass), and the PillCam SB2 capsule
endoscope. Although wireless VCE is a good noninvasive
diagnostic tool able to scan the entire bowel, the source of
bleeding could not be identified owing to its intermittent
nature. However, it is possible to perform a DBE as
a diagnostic and therapeutic procedure, potentially guided
by the VCE results. The DBE is a somewhat invasive
procedure able to treat the AVMs and is a good alternative
to surgical laparotomy. On the other hand, DBE requires
accurate management: the procedure has to be performed
under the surveillance of a cardiothoracic surgeon and
cardiac anesthesiologist. The patient must be sedated,
intubated, kept supine, and supported by inotropes to
face the anesthetic vasoplegia. In our case the DBE
was performed using the 9.5-mm enteroscope Fujinon
EN-450T5; t-type (Fujinon Inc, Saitama city, Japan).7
More important, in patients with LVADs, it is crucial to
avoid excessive upper abdominal pressure because this
may lead to the reduction of venous blood return impairing
the preload required for correct LVAD function.
There have only been a few written reports on VCE and
DBE in patients with LVADs.1,3,7,8 However, our case is the
first in which DBE treatment of AVMs and a Dieulafoy
lesion have been successfully guided by VCE results.The Journal of Thoracic and CaIn conclusion, we suggest this diagnostic and therapeutic
algorithm (Figure 2) in the patient with continuous-flow
LVAD and occult GI bleeding. It can allow the detection
(VCE) of lesions in the reach of a therapeutic enteroscope
(DBE), avoiding the need for more invasive tests, including
mesenteric angiography, exploratory laparotomy, or on-
table enteroscopy.References
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